Skip to main content
OpenTrials
Completed

NCT Number: NCT03226002

Which Nostril Should be Used for Nasotracheal Intubation With Airtraq NT®: the Right or Left? A Randomized Clinical Trial

After Ethics committee approval investigators decided to enroll 40 patients ASA I-II, 18-60 years of age undergoing maxillofascial, oral and double chin surgery to determine which nostril is more suitable for nasotracheal intubation with nasotracheal Airtraq. We primay aimed to compare the glottis visualization time, intubation time and total intubation times.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nasotracheal Intubation

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kocaeli University School of Medicine

Kocaeli, 41900, Turkey (Türkiye)

About this study

After Ethics committee approval, investigators decided to enroll 40 pateints ASA I-II, 18-60 years of age undergoing maxillofascial, oral and double chin surgery to determine which nostril is more suitable for nasotracheal intubation with nasotracheal Airtraq. In addition is the 90° anti-clockwise rotation of the tip of the tube helpful to insert the tube into the trachea. Patients were randomized into right and the left nostril groups. After standard anesthesia induction with propofol and fentanyl, rocuronium was used for muscle relaxation. Primary aim of this prospective study was to compare the glottis visualization time, intubation time and total intubation times. The Cormack-Lehane grades, the need for optimization, tube adjustment maneuvers, hemodynamic data, occurrence of epistaxis of the patients were recorded during the process.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-65 years of age
  • undergoing elective maxillofacial surgery
  • dental surgery
  • plastic surgery requiring nasotracheal intubation
  • ASA I-II

Exclusion criteria

  • >18 years and > 65 years
  • BMI> 35
  • ASA III-IV
  • fasted patients
  • patients do not require nasotracheal intubation

Treatment and study plan

Airtraq NT

Device

channeled video laryngoscope for nasotracheal intubation

Primary outcomes

  1. insertion time of the device

    Time frame: 20 seconds

    handling the device till the optimal glottis visualization occurred

  2. nasotracheal intubation time with the device

    Time frame: 30 seconds

    handling the device till the visualization of tracheal tube through the vocal cords

  3. total nasotracheal intubation time with the device

    Time frame: 40 seconds

    handling the device till the confirmation of nasotracheal intubation with end-tidal carbodioxide

Secondary outcomes

  1. optimisation maneuvers during intubation with the device

    Time frame: 20 seconds

    need for optimisation maneuvers during nasotracheal intubation

  2. minor complications related to the device

    Time frame: 40 seconds

    epistaxis, nose pain, bronchospasm

Sponsors and collaborators

Lead sponsor

Kocaeli University

Other

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jul 21, 2017
Registry last updated
Aug 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.